Penicillin allergy linked to infections

New research suggests that penicillin allergy increases the risk of infections with methicillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile.

Researchers used data from UK general practice to match 64,141 adults with penicillin allergy to 237,258 controls. During a mean follow-up of approximately six years, 442 people with penicillin allergy and 923 controls developed MRSA, while 442 and 1,246 respectively developed C. difficile.

Patients with penicillin allergy were 70 per cent less likely to be prescribed penicillin than controls but were about four times more likely to receive macrolides (incidence rate ratio [IRR] 4.15) or clindamycin (IRR 3.89), twice as likely to receive fluoroquinolones (IRR 2.10) or tetracyclines (IRR 1.75) and 26 per cent more likely to receive sulphonamides.

After adjusting for confounders, patients with penicillin allergy were 69 per cent more likely to develop MRSA and 26 per cent more likely to develop C. difficile. Increased use of antibiotics that are alternatives to betalactams accounted for 55 and 35 per cent of the increased risk of MRSA and C. difficile respectively.

Previous studies have reported that 95 per cent of patients who reported penicillin allergy were tolerant to the antibiotic, while 80 per cent of patients who show an immediate hypersensitivity reaction to penicillin are no longer allergic 10 years later.

“As infections with resistant organisms increase, systematic efforts to confirm or rule out the presence of true penicillin allergy may be an important public health strategy to reduce the incidence of MRSA and C. difficile,” the authors conclude.

(BMJ 2018; 361:k2400)

Latest discussions

  1. Protective equipment shortage

    We are told that Pharmacy staff are exem...

  2. Are pharmacists guinea pigs for covid19

    I am a accuracy checking pharmacy techni...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.